Literature DB >> 16899540

Unusual N-glycan structures in alpha-mannosidase II/IIx double null embryos identified by a systematic glycomics approach based on two-dimensional LC mapping and matrix-dependent selective fragmentation method in MALDI-TOF/TOF mass spectrometry.

Megumi Hato1, Hiroaki Nakagawa, Masaki Kurogochi, Tomoya O Akama, Jamey D Marth, Michiko N Fukuda, Shin-Ichiro Nishimura.   

Abstract

alpha-Mannosidase IIx (MX) is an enzyme closely related to alpha-mannosidase II (MII), a key enzyme in N-glycan biosynthesis that catalyzes the first step in conversion of hybrid- to complex-type N-glycans in Golgi apparatus. Recently we generated MII/MX double knock-out mice and found that double nulls completely lack the complex-type N-glycans (Akama, T. O., Nakagawa, H., Wong, N. K., Sutton-Smith, M., Dell, A., Morris, H. R., Nakayama, J., Nishimura, S.-I., Pai, A., Moremen, K. W., Marth, J. D., and Fukuda, M. N. (2006) Essential and mutually compensatory roles of alpha-mannosidase II and alpha-mannosidase IIx in N-glycan processing in vivo in mice. Proc. Natl. Acad. Sci. U. S. A. 103, 8983-8988). In the present study, we determined minor but unusual N-glycan structures found in MII/MX double knock-out mice. We identified such N-glycans by a systematic glycomics approach applying a two-dimensional LC mapping database and matrix-dependent selective fragmentation technique in MALDI-TOF/TOF MS, a highly sensitive and reliable technique that provides specific fragmentations enabling the determination of precise oligosaccharide structures including regioisomers (Kurogochi, M., and Nishimura, S.-I. (2004) Structural characterization of N-glycopeptides by matrix-dependent selective fragmentation of MALDI-TOF/TOF tandem mass spectrometry. Anal. Chem. 76, 6097-6101). Quantitative profiling of all N-glycan structures including minor components from MII/MX nulls, MII nulls, MX nulls, and wild-type mice at embryonic day 15.5 yielded a total of 37 species when structural heterogeneity was reduced by the removal of the sialic acids. Among six unusual N-glycan structures, two glycoforms were novel and were found only in MII/MX double nulls. We characterize such structure as pseudocomplex-type N-glycans. The present study demonstrated that use of the versatile matrix-dependent selective fragmentation method in MALDI-TOF/TOF MS greatly accelerates detailed structural analysis of a trace amount of N-glycans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16899540     DOI: 10.1074/mcp.M600213-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  11 in total

Review 1.  Mass spectrometry and glycomics.

Authors:  Joseph Zaia
Journal:  OMICS       Date:  2010-08

2.  Glycans, Glycosite, and Intact Glycopeptide Analysis of N-Linked Glycoproteins Using Liquid Handling Systems.

Authors:  Shao-Yung Chen; Mingming Dong; Ganglong Yang; Yangying Zhou; David J Clark; T Mamie Lih; Michael Schnaubelt; Zichen Liu; Hui Zhang
Journal:  Anal Chem       Date:  2020-01-03       Impact factor: 6.986

Review 3.  Recent advances in sialic acid-focused glycomics.

Authors:  Huan Nie; Yu Li; Xue-Long Sun
Journal:  J Proteomics       Date:  2012-04-05       Impact factor: 4.044

4.  Analytical performance of immobilized pronase for glycopeptide footprinting and implications for surpassing reductionist glycoproteomics.

Authors:  Eric D Dodds; Richard R Seipert; Brian H Clowers; J Bruce German; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

5.  Threshold in stage-specific embryonic glycotypes uncovered by a full portrait of dynamic N-glycan expression during cell differentiation.

Authors:  Maho Amano; Misa Yamaguchi; Yasuhiro Takegawa; Tadashi Yamashita; Michiyo Terashima; Jun-Ichi Furukawa; Yoshiaki Miura; Yasuro Shinohara; Norimasa Iwasaki; Akio Minami; Shin-Ichiro Nishimura
Journal:  Mol Cell Proteomics       Date:  2009-12-14       Impact factor: 5.911

6.  Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS).

Authors:  Jonas Denecke; Christian Kranz; Manfred Nimtz; Harald S Conradt; Thomas Brune; Hermann Heimpel; Thorsten Marquardt
Journal:  Glycoconj J       Date:  2007-12-29       Impact factor: 2.916

7.  Expression, purification and preliminary crystallographic analysis of Drosophila melanogaster lysosomal α-mannosidase.

Authors:  I Nemčovičová; M Nemčovič; S Sesták; M Plšková; I B H Wilson; J Mucha
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-07-31

8.  Mannosidase 2, alpha 1 deficiency is associated with ricin resistance in embryonic stem (ES) cells.

Authors:  Wei Wang; Christine Hale; Dave Goulding; Stuart M Haslam; Bérangère Tissot; Christopher Lindsay; Stephen Michell; Rick Titball; Jun Yu; Ana Luisa Toribio; Raffaella Rossi; Anne Dell; Allan Bradley; Gordon Dougan
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

9.  N-glycans: phenotypic homology and structural differences between myocardial cells and induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Takuji Kawamura; Shigeru Miyagawa; Satsuki Fukushima; Akira Yoshida; Noriyuki Kashiyama; Ai Kawamura; Emiko Ito; Atsuhiro Saito; Akira Maeda; Hiroshi Eguchi; Koichi Toda; Jong-Kook Lee; Shuji Miyagawa; Yoshiki Sawa
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

10.  Swainsonine reduces 5-fluorouracil tolerance in the multistage resistance of colorectal cancer cell lines.

Authors:  Jun Hamaguchi; Hiroaki Nakagawa; Masato Takahashi; Takeaki Kudo; Naoya Kamiyama; Bailong Sun; Takahiro Oshima; Yuji Sato; Kisaburo Deguchi; Satoru Todo; Shin-Ichiro Nishimura
Journal:  Mol Cancer       Date:  2007-09-21       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.